FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,725 | -26.4% | 10,145 | +3.7% | 0.00% | – |
| Q2 2023 | $68,886 | +14.6% | 9,785 | +0.9% | 0.00% | – |
| Q1 2023 | $60,128 | -0.9% | 9,698 | +2.0% | 0.00% | – |
| Q4 2022 | $60,648 | -26.0% | 9,506 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $82,000 | -35.9% | 9,540 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $128,000 | -13.5% | 9,405 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $148,000 | -37.8% | 9,712 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $238,000 | +59.7% | 10,395 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $149,000 | +27.4% | 10,706 | -2.3% | 0.00% | – |
| Q2 2021 | $117,000 | +112.7% | 10,960 | +161.5% | 0.00% | – |
| Q1 2021 | $55,000 | -35.3% | 4,192 | +0.3% | 0.00% | – |
| Q4 2020 | $85,000 | – | 4,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $25,566,000 | 5.41% |
| Flagship Pioneering Inc. | 12,674,120 | $256,905,000 | 4.68% |
| Birchview Capital, LP | 314,143 | $6,368,000 | 3.67% |
| Monashee Investment Management LLC | 560,360 | $11,359,000 | 1.50% |
| Artal Group S.A. | 1,720,720 | $34,879,000 | 0.75% |
| Alphabet Inc. | 500,901 | $10,153,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,270,000 | 0.48% |
| Casdin Capital, LLC | 216,216 | $4,383,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 258,700 | $5,244,000 | 0.08% |
| Woodline Partners LP | 103,040 | $2,089,000 | 0.06% |